Scott N Boyle C4 Therapeutics, Inc. (CCCC) insider trading activity
Scott N Boyle is Chief Business Officer of C4 Therapeutics, Inc.. Currently has a direct ownership of 52,330 shares of CCCC, which is worth approximately $305,083. The most recent transaction as insider was on Feb 14, 2024, when has been sold 27,300 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
52.3K
0%
3M change
95.52%
12M change
Total Value Held
$305,083
Scott N Boyle Transaction History
SNB
Scott N Boyle
Chief Business Officer
Watertown, MA